Viatris stock trades at 17.06 euros on October 31
Published on 11/01/2026 at 13:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCompany Profile And Trading Focus
- Viatris operates across branded, generic and biosimilar medicines.
- The healthcare group serves developed, Chinese, Japanese, Australian, New Zealand and emerging markets.
Viatris stock traded at 17.06 euros on Lang & Schwarz at 13:04 CET on Saturday, October 31, 2026. The quote gives investors a current reference for the US pharmaceutical group ahead of the next trading session.
Viatris operates across branded prescription medicines, generics, complex generics, biosimilars and active pharmaceutical ingredients. Its business spans developed markets, Greater China, Japan, Australia, New Zealand and emerging markets.
Portfolio Supports Defensive Positioning
The broad product mix gives Viatris exposure to established therapies as well as lower-cost generic treatments and biosimilar medicines. For investors, future attention remains on prescription demand, product launches, pricing and the company's ability to manage its international footprint.
Investors can follow the real-time quote of Viatris stock for further trading updates.
Viatris stock at a glance
- Company: Viatris Inc.
- ISIN: US92556V1061
- Sector: Healthcare
- Lang & Schwarz quote: 17.06 euros on October 31, 2026, at 13:04 CET
US market developments can be followed in the current S&P 500 market reports.
More news and analyses on Viatris stock provide further company and market context.
